{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:27:41Z","timestamp":1754152061526,"version":"3.41.2"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1136\/ijgc-2023-005127","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T05:15:57Z","timestamp":1709529357000},"page":"447-450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Health-related quality of life metrics as endpoints in surgical trials: hype or hope?"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8606-6523","authenticated-orcid":false,"given":"Robert","family":"Armbrust","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0193-0053","authenticated-orcid":false,"given":"Jennifer","family":"Davies-Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5963-6623","authenticated-orcid":false,"given":"Jalid","family":"Sehouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2023-005127_bb0010","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1136\/ijgc-2021-002951","article-title":"European Society of Gynaecological Oncology guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking surgery","volume":"31","author":"Fotopoulou","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2023-005127_bb0015","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","article-title":"Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials","volume":"115","author":"du Bois","year":"2009","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2023-005127_bb0020","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/1471-0528.17041","article-title":"Quality of life from cytoreductive surgery in advanced ovarian cancer: investigating the association between disease burden and surgical complexity in the international, prospective, SOCQER-2 cohort study","volume":"129","author":"Sundar","year":"2022","journal-title":"BJOG"},{"key":"10.1136\/ijgc-2023-005127_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14184362","article-title":"Investigating the impact of ultra-radical surgery on survival in advanced ovarian cancer using population-based data in a multicentre UK study","volume":"14","author":"Cummins","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1136\/ijgc-2023-005127_bb0030","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1136\/ijgc-2023-004804","article-title":"Impact of gynecological cancers on health-related quality of life: historical context, measurement instruments, and current knowledge","volume":"33","author":"Gil-Ibanez","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2023-005127_bb0035","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ygyno.2017.06.007","article-title":"The impact of type and number of bowel resections on anastomotic leakage risk in advanced ovarian cancer surgery","volume":"146","author":"Grimm","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-005127_bb0040","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jso.21288","article-title":"Intra-abdominal tumor dissemination pattern and surgical outcome in 214 patients with primary ovarian cancer","volume":"99","author":"Sehouli","year":"2009","journal-title":"J Surg Oncol"},{"key":"10.1136\/ijgc-2023-005127_bb0045","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1097\/IGC.0000000000000551","article-title":"Patient-reported outcomes after extensive (ultraradical) surgery for ovarian cancer: results from a prospective longitudinal feasibility study","volume":"25","author":"Soo Hoo","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2023-005127_bb0050","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/IGC.0b013e3182842fc4","article-title":"Does extensive upper abdomen surgery during primary cytoreduction impact on long-term quality of life","volume":"23","author":"Angioli","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2023-005127_bb0055","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2023-005127_bb0060","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1056\/NEJMoa1808424","article-title":"A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms","volume":"380","author":"Harter","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2023-005127_bb0065","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/ijgc-2019-000682","article-title":"TRUST: trial of radical upfront surgical therapy in advanced ovarian cancer (ENGOT Ov33\/AGO-OVAR Op7)","volume":"29","author":"Reuss","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2023-005127_bb0070","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00404-019-05321-7","article-title":"Prehabilitation programs and ERAS protocols in gynecological oncology: a comprehensive review","volume":"301","author":"Schneider","year":"2020","journal-title":"Arch Gynecol Obstet"},{"key":"10.1136\/ijgc-2023-005127_bb0075","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1136\/ijgc-2020-001551","article-title":"LION-PAW (lymphadenectomy in ovarian neoplasm) sexual function assessment: a prospective sub-study of the LION trial","volume":"30","author":"Hasenburg","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2023-005127_bb0080","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1056\/NEJMoa1806395","article-title":"Minimally invasive versus abdominal radical hysterectomy for cervical cancer","volume":"379","author":"Ramirez","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2023-005127_bb0085","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2023.41.17_suppl.LBA5511","volume":"41","author":"Plante","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2023-005127_bb0090","doi-asserted-by":"crossref","first-page":"694","DOI":"10.2522\/ptj.20120088","article-title":"Development and validation of a self-report lower-extremity lymphedema screening questionnaire in women","volume":"93","author":"Yost","year":"2013","journal-title":"Phys Ther"},{"key":"10.1136\/ijgc-2023-005127_bb0095","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s00404-022-06779-8","article-title":"Lymphedema after pelvic and para-aortic lymphadenectomy-results of a systematic evaluation in patients with cervical and endometrial carcinoma","volume":"307","author":"Armbrust","year":"2023","journal-title":"Arch Gynecol Obstet"},{"key":"10.1136\/ijgc-2023-005127_bb0100","doi-asserted-by":"crossref","first-page":"800","DOI":"10.2105\/AJPH.72.8.800","article-title":"Self-rated health: a predictor of mortality among the elderly","volume":"72","author":"Mossey","year":"1982","journal-title":"Am J Public Health"},{"key":"10.1136\/ijgc-2023-005127_bb0105","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7525-7-102","article-title":"Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008","volume":"7","author":"Montazeri","year":"2009","journal-title":"Health Qual Life Outcomes"},{"key":"10.1136\/ijgc-2023-005127_bb0110","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1007\/s11136-023-03404-2","article-title":"Updated normative data for the EORTC QLQ-C30 in the general Dutch population by age and sex: a cross-sectional panel research study","volume":"32","author":"de Ligt","year":"2023","journal-title":"Qual Life Res"},{"key":"10.1136\/ijgc-2023-005127_bb0115","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ygyno.2011.11.032","article-title":"The association between quality of life domains and overall survival in ovarian cancer patients during adjuvant chemotherapy: a Gynecologic Oncology Group study","volume":"124","author":"von Gruenigen","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-005127_bb0120","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ygyno.2017.07.121","article-title":"Quality of life is significantly associated with survival in women with advanced epithelial ovarian cancer: an ancillary data analysis of the NRG Oncology\/Gynecologic Oncology Group (GOG-0218) study","volume":"147","author":"Phippen","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2023-005127_bb0125","first-page":"931","article-title":"Development of the Berlin symptom checklist ovary (BSCL-O) for the measurement of quality of life of patients with primary and recurrent ovarian cancer: results of a phase I and II study","volume":"18","author":"Koensgen","year":"2010","journal-title":"Support Care Cancer"},{"key":"10.1136\/ijgc-2023-005127_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100176","article-title":"Impact of health-related quality of life (HRQoL) on short-term mortality in patients with recurrent ovarian, Fallopian or peritoneal carcinoma (the NOGGO-AGO Qol prognosis-score-study): results of a meta-analysis in 2209 patients","volume":"6","author":"Richter","year":"2021","journal-title":"ESMO Open"},{"key":"10.1136\/ijgc-2023-005127_bb0135","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11136-017-1729-8","article-title":"Measuring what matters MOST: validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer","volume":"27","author":"King","year":"2018","journal-title":"Qual Life Res"},{"key":"10.1136\/ijgc-2023-005127_bb0140","doi-asserted-by":"crossref","DOI":"10.1186\/1757-2215-6-17","article-title":"Longitudinal health-related quality of life assessment: implications for prognosis in ovarian cancer","volume":"6","author":"Gupta","year":"2013","journal-title":"J Ovarian Res"},{"key":"10.1136\/ijgc-2023-005127_bb0145","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00404-020-05847-1","article-title":"Preoperative quality of life as prediction for severe postoperative complications in gynecological cancer surgery: results of a prospective study","volume":"303","author":"Sehouli","year":"2021","journal-title":"Arch Gynecol Obstet"},{"key":"10.1136\/ijgc-2023-005127_bb0150","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.0363","article-title":"Patient experience captured by quality-of-life measurement in oncology clinical trials","volume":"3","author":"Haslam","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1136\/ijgc-2023-005127_bb0155","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/S0140-6736(11)61256-7","article-title":"Reporting quality of life in clinical trials: a CONSORT extension","volume":"378","author":"Calvert","year":"2011","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2023-005127_bb0160","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s11605-009-1052-y","article-title":"Reporting on quality of life in randomised controlled trials in gastrointestinal surgery","volume":"14","author":"Bridoux","year":"2010","journal-title":"J Gastrointest Surg"},{"key":"10.1136\/ijgc-2023-005127_bb0165","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s11136-010-9793-3","article-title":"Patterns of reporting health-related quality of life outcomes in randomized clinical trials: implications for clinicians and quality of life researchers","volume":"20","author":"Brundage","year":"2011","journal-title":"Qual Life Res"},{"key":"10.1136\/ijgc-2023-005127_bb0170","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1200\/JCO.2003.12.121","article-title":"Beyond the development of health-related quality-of-life (HRQOL) measures: a checklist for evaluating HRQOL outcomes in cancer clinical trials--does HRQOL evaluation in prostate cancer research inform clinical decision making?","volume":"21","author":"Efficace","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2023-005127_bb0175","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/jama.2013.879","article-title":"Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension","volume":"309","author":"Calvert","year":"2013","journal-title":"JAMA"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24013380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24013380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2023-005127","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T12:40:13Z","timestamp":1753101613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24013380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1048891X24013380"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2023-005127","relation":{},"ISSN":["1048-891X"],"issn-type":[{"type":"print","value":"1048-891X"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Health-related quality of life metrics as endpoints in surgical trials: hype or hope?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2023-005127","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}